Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee

Phase 4 Unknown 80 enrolled Cabrini Medical Centre Genzyme, a Sanofi Company · collab

Non-randomizedParallel-groupSingle-blindTreatment

Summary

That Hylan G-F 20 may act to protect cartilage from the expected degree of degradation over a 12 month period in subjects with moderate to marked osteoarthritis of the knee

Timeline

Start: 2006-01
Primary completion: —
Completion: 2006-01

Publications

Wang Y, Hall S, Hanna F, Wluka AE, Grant G, Marks P, Feletar M, Cicuttini FM. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord. 2011 Aug 24;12:195. doi: 10.1186/1471-2474-12-195.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hylan G-F 20	Other / unclassified	2 ml	Other

Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee

Summary

Timeline

Publications

Drugs

Indications